Literature DB >> 4042489

Parathormone, calcitonin, and vitamin D metabolites during normal fracture healing in geriatric patients.

Y Meller, R S Kestenbaum, S Shany, D Galinsky, I Zuili, N Yankovitch, J Giat, A Conforti, G Torok.   

Abstract

In order to study the role of calcium-regulating hormones during callus formation in elderly patients, serum levels of parathormone (PTH), calcitonin (CT), 25-hydroxyvitamin D [25-OH-D], 1,25-dihydroxyvitamin D [1,25(OH)2D], 24,25-dihydroxyvitamin D [24,25(OH)2D], and calcium (Ca) were determined in 41 patients with fractures of long bones, primarily hip fractures. The parameters were measured on admission and after eight weeks. There were almost no changes in hormone serum levels during bone repair, except for a decrease in serum levels of 1,25(OH)2D from 25.3 +/- 2.3 pg/ml on admission to 21.0 +/- 2.0 pg/ml eight weeks later (p less than .001). Patients with fractures compared to normal elderly humans have lower serum levels of PTH (0.99 +/- 0.06 ng/ml versus 1.88 +/- 0.34 ng/ml; p less than .001), 25-OH-D (10.7 +/- 1.0 ng/ml versus 17.1 +/- 1.8 ng/ml; p less than .001), and Ca (9.1 +/- 0.1 mg% versus 9.7 +/- 0.1 mg%; p less than .001) and higher serum levels of 1,25(OH)2D (25.3 +/- 2.3 pg/ml versus 17.1 +/- 2.3 pg/ml; p less than .001). Female patients have lower serum levels of 24,25(OH)2D compared to males (1.65 +/- 0.15 ng/ml versus 2.06 +/- 0.29 ng/ml; p less than .05). A similar trend was noted in serum CT levels during callus formation (0.12 +/- 0.02 ng/ml versus 0.16 +/- 0.02 ng/ml; p less than .05). Patients with subcapital fractures of the femur have significantly lower serum levels of all vitamin D metabolites on admission, compared with patients suffering from extracapsular fractures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4042489

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  Effectiveness of elcatonin for alleviating pain and inhibiting bone resorption in patients with osteoporotic vertebral fractures.

Authors:  Shinya Tanaka; Akira Yoshida; Shinjiro Kono; Tadanori Oguma; Kyoichi Hasegawa; Manabu Ito
Journal:  J Bone Miner Metab       Date:  2016-11-09       Impact factor: 2.626

2.  Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2.

Authors:  Corine Martineau; Roy Pascal Naja; Abdallah Husseini; Bachar Hamade; Martin Kaufmann; Omar Akhouayri; Alice Arabian; Glenville Jones; René St-Arnaud
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

3.  Changes in the serum level of vitamin d during healing of tibial and femoral shaft fractures.

Authors:  Hossein Ettehad; Ahmadreza Mirbolook; Fereshteh Mohammadi; Mohammadsadegh Mousavi; Hannan Ebrahimi; Ardeshir Shirangi
Journal:  Trauma Mon       Date:  2014-01-25

4.  The biochemical and histological analysis of subcutaneous calcitonin and intramedullary methylprednisolone on bone repair after bone marrow ablation: an experimental comparative study in rats.

Authors:  Salim Ersozlu; Bartu Sarisozen; Ozgur Ozer; Saduman Balaban Adim; Orcun Sahin
Journal:  J Exp Orthop       Date:  2017-07-20

5.  Time course of 25(OH)D3 vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD).

Authors:  Christoph Wölfl; Christoph Wöfl; Sarah Englert; Arash A Moghaddam; Gerald Zimmermann; Heinrich Schmidt-Gayk; Gerhard Schmidt-Gayk; Bernd Höner; Aidan Hogan; Marcus Lehnhardt; Paul A Grützner; Leila Kolios
Journal:  BMC Musculoskelet Disord       Date:  2013-01-03       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.